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Abstract 
Background: Hypotension remains the most common complication following 
spinal anesthesia in cesarean sections. Despite using various preventive 
measures, hypotension occurs in most cases; vasopressors are often required. 
The current study evaluated the safety and efficacy of prophylactic 
phenylephrine infusion in preventing spinal anesthesia-induced hypotension in 
the Cesarean Section.  
Materials and Methods: A total of 50 parturients aged 20-35 years with 
American Society of Anesthesiologists (ASA) grade II, scheduled for elective 
cesarean sections were randomly allocated into one of the two groups. Group 
A (n=25) received intravenous prophylactic phenylephrine infusion at 
100μg/min for 3min after spinal anesthesia using a syringe pump. Each minute, 
systolic arterial pressure (SAP) was measured, and infusion stopped if SAP > 
baseline and continued if less than or equal to baseline systolic arterial pressure. 
Intravenous phenylephrine bolus 100μg was given when SAP decreased to 
<80% of baseline. Group B (n=25) received only intravenous phenylephrine 
bolus 100μg when SAP decreased to <80% of baseline. After 1 minute of spinal 
anesthesia, Heart Rate (HR), SAP, and diastolic blood pressure (DBP) were 
recorded every minute until the baby's extraction. After the delivery of the 
baby, APGAR scores at 1 minute and 5 minutes were noted. Umbilical artery 
blood was sent for analysis of the pH. The total volumes of study solutions 
given up to the time of delivery of the baby were recorded.  
Results: Phenylephrine infusion decreased the incidence and frequency of hypotension compared with control and 
the phenylephrine dose was much higher in the infusion group than in the control group (p=0.0001). None of the 
patients had any incidence of nausea or vomiting. There was no significant difference in umbilical artery blood pH 
and no reduction in the APGAR scores. HR was significantly slower in the infusion group compared with the control 
group.  
Conclusion: A prophylactic infusion of phenylephrine100 μg/min in patients receiving spinal anesthesia for elective 
cesarean delivery decreased the incidence of hypotension and without any deleterious neonatal outcome.  
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Introduction 
Spinal anesthesia is the preferred anesthetic technique 
for cesarean sections nowadays to prevent general 
anesthesia-related complications like failed intubation, 
aspiration, and depressant effect of general anesthetics 
on neonates (1). However, the incidence of 
hypotension is 75-85% with this technique which is 
detrimental to both mother and fetus (2). A mother with 
hypotension is associated with nausea and vomiting 
and risks reduced consciousness, respiratory 
depression, pulmonary aspiration, and cardiac arrest 
(3). Hypotension had detrimental effects on neonates, 
such as decreased uteroplacental flow, impaired fetal 
oxygenation with asphyxia, and fetal acidosis (4). 
Preventive measures for hypotension include adequate 
preload (10-15ml/kg), lateral tilt, wedge, and 
vasopressors use (5). Ephedrine is the preferred 
vasopressor in cesarean sections. It has direct and 
indirect action mechanisms, stimulating mainly beta 
receptors (β1 and β2), causing increased cardiac 
output, heart rate, and systolic and diastolic blood 
pressure. However, it can cause supraventricular 
tachycardia, tachyphylaxis, and fetal acidosis (6, 7). 
Various studies have shown Ephedrine to be associated 
with a dose-related propensity to depress fetal pH and 
base excess. Phenylephrine is a selective α1 adrenergic 
agonist that is as effective as Ephedrine in treating 
spinal hypotension with a better neonatal outcome and 
fetal acid-base status (7-9). If tachycardia is 
undesirable, Phenylephrine may be better than 
Ephedrine. The APGAR scores and umbilical artery 
blood pH measurements were used to indicate the 
adequacy of placental perfusion. Acidotic changes in 
the umbilical artery were the sensitive indicators of 
uteroplacental insufficiency. 
Small studies are available related to 
prophylactic phenylephrine infusion for the treatment 
of hypotension following spinal anesthesia. Hence, the 
study aims to determine the efficacy of prophylactic 
Phenylephrine on the incidence of hypotension in 
patients receiving a subarachnoid block for cesarean 
sections and assess the prophylactic effect of 
Phenylephrine on maternal hemodynamics and its 
consequences. The primary outcome measure was the 
assessment of prophylactic Phenylephrine on maternal 
hemodynamics (hypotension, nausea, and vomiting). 
In contrast, the secondary outcome was to assess the 
effect of prophylactic Phenylephrine on neonatal 
umbilical cord blood pH, umbilical blood artery pH, 





A prospective, randomized, open-label, controlled 
hospital-based observational study was conducted at 
Govt. District Headquarters Hospital and Apollo 
Institute of Medical Science and Research, Chittoor, 
AP, under PPP Mode Medical College, Chittoor, AP. 
The hospital ethical committee approved the 
study protocol. Written informed consent was taken 
from 50 pregnant women from the American Society 
of Anesthesiologists (ASA) grade II (woman with 
uncomplicated pregnancy assigned ASA grade II) who 
were scheduled for elective Caesarean section during 
the study period under spinal anesthesia. 
Phenylephrine (Phenylephrine Hydrochloride 
Injection, Neon Laboratories Ltd. Mumbai, India) was 
used. For randomization, patients were distributed into 
two groups based on the random sampling method.  
Inclusion criteria are singleton full-term 
pregnant women, age 20- 35yrs of ASA grade II. 
Scheduled for elective cesarean and the age group 20-
35 yrs is selected for the study because of commoner 
age groups in this region. Exclusion criteria are 
pregnant above 35yrs, patients below 20yrs, patients 
having resting blood pressure > 140/90mm of Hg, 
history of hypertension, preeclampsia/eclampsia, 
hyperthyroidism, Patients having co-existing 
neurological, cerebrovascular, cardiovascular, renal, 
metabolic, psychiatric disorder, Patients with 
glaucoma, occlusive vascular disorder, History of 
Hypersensitivity to local anesthetics and any 
contraindications to spinal anesthesia. 
 
Patients and drug allocation: Group A patients 
received intravenous prophylactic phenylephrine 
infusion at 100µg/min for 3min after completion of 
intrathecal injection. Then each min SAP was 
measured and infusion stopped if SAP > baseline and 
continued. Intravenous phenylephrine bolus 100µg 
was given when SAP is decreased to < 80% of 
baseline. Group B patients received intravenous 
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phenylephrine bolus 100µg when SAP is decreased to 
< 80% of baseline.  
On arrival to the operation theatre, heart rate 
(ECG), blood pressure (non-invasive BP), respiratory 
rate, hemodynamics, and vitals were monitored. 
HR, SBP, and DPB every minute after spinal 
anesthesia induction to the baby's extraction, the 
incidence of adverse hemodynamic effects, the 
incidence of nausea and vomiting, Umbilical artery 
blood pH, APGAR score at one and 5minutes.  
All parturients were premedicated with 
injection ranitidine 50mg intravenously one hour 
before surgery. 
After premedication, patients were allowed to 
rest undisturbed for several minutes, during which SAP 
was measured every 1-2 min. This was continued until 
measurements became consistent. Baseline SAP, DAP, 
and HR were taken as the mean of the two recordings. 
In the operation theatre, baseline vital signs were 
recorded using Multiparameter Monitor. Patients 
preloaded with ringer lactate solution, 10ml/kg over 
15minutes after securing intravenous line with 18 
gauze cannula and continued at 10 mL/min. 
 
Spinal anesthesia-induced with patients in the 
lateral position: After skin infiltration with lidocaine, 
a 23-gauge Quinche Babcock needle was inserted at 
L2-3 or L3-4vertebral interspace, and the hyperbaric 
0.5% bupivacaine 2.0 mL was injected intrathecally. 
SAP was measured at 1-min intervals beginning 1 min 
after spinal injection. 
Immediately after the completion of the 
intrathecal injection, phenylephrine infusion was 
started in group A patients at 1 mL/min (100 µg/min), 
whereas group B patients did not receive it. Infusions 
were administered with a syringe pump connected to 
the intravenous line and continued for a minimum of 3 
minutes, then the infusion was either stopped or 
continued according to the protocol based on the SAP 
measurement at each minute.  
After intrathecal injection of bupivacaine, the 
upper sensory level of anesthesia was measured by 
assessing loss of pinprick discrimination. After 1 
minute of spinal anesthesia; HR, SAP, and DBP were 
recorded every minute till the extraction of the baby. 
The dosing regimens of Phenylephrine were selected 
based on literature (10,11,23).  
After delivery, oxytocin 20 IU in 1000ml saline 
was given by slow intravenous infusion. APGAR 
scores were assessed 1 and 5 min after delivery. 
Umbilical artery blood was taken from a double-
clamped segment of the umbilical cord for immediate 
blood gas analysis. 
 
Statistics: The observations are expressed as 
Mean±standard deviation. The baseline hemodynamic 
values and the postspinal hemodynamic changes at 
various time intervals were compared using the 
unpaired “t” test. Chi-square and Fischer Exact test 
have been used to find the significance of study 
parameters. A “P-value of ≤ 0.05” was considered to 
be statistically significant. 
 
Results 
The age of the patients ranged from 20-30 years. The 
mean age in group A was 25.8400 (SD 2.89) years, in 
group B was 25.04 (SD 2.28) years. The weight of the 
patients ranged from 55-75 kgs. In group A, the mean 
weight was 64.20 (SD 5.63), in group B was 64.88 (SD 
2.33) kg. The height of the patients ranged from 150-
168cms. The mean height in group A was 157.72 
(SD4.83), in group B was 155. 68 (SD 2.64) cm. The 
level of a sensory block obtained was comparable in 
both the groups and most of the patients had an average 
blockade level of T6. The mean maternal heart rates 
range in groups A and B were 86.96 -95.00 bpm, 
90.08-95.00, respectively. The heart rate was 
significantly lower in the infusion group in the 1st, 2nd, 
10th, and 11th minutes. 
 
SBP Variations: The mean systolic blood pressure 
variations in group A and group B after spinal 
anesthesia were 123.00- 128.47 mm Hg and 98.44-
126.84 mm Hg, respectively. Both the groups had 
similar preinduction SBP; however, after spinal 
anesthesia, the mean systolic blood pressure was 
higher in the infusion group and was statistically 
significant (Table 2). 
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DBP Variations: The mean diastolic blood pressure 
variations in group A and group B after spinal 
anesthesia were 72.7600-81.0000 mm Hg and 
63.4800- 74.2400 mm Hg, respectively. 
Both the groups had similar pre-induction DBP; 
however, after SPINAL ANAESTHESIA the mean 
diastolic blood pressure was higher in the infusion 
group and was statistically significant. 
 
Mean blood pressure variations: The variations in 
mean Mean blood pressure in group A, group B after 
spinal anesthesia was in the range of 89.6000 -95.0000 
mm Hg, 76.4000-91.7600 mm Hg, respectively. Both 
the groups had similar preinduction MBP; however, 
after spinal anesthesia, the mean Mean blood pressure 
was higher in the infusion group and was statistically 
significant. 
Incidence of hypotension: The incidence of 
hypotension in group A, group B was 1 (3.57%) and 25 
(100%), respectively, and the number of episodes of 
hypotension in group A and group B was 2 and 54 
episodes, respectively. It is considered to be 
statistically significant with a p-value of 0.0001. 
In group A, there were two episodes of 
hypotension in 1 patient who required two boluses of 
Phenylephrine in addition to the infusion for the 
correction of hypotension. In group B, all 25 patients 
had episodes of hypotension which required treatment 
with bolus doses of Phenylephrine. 
Complications: There were no incidences of 
complications such as nausea and vomiting after 
induction of spinal anesthesia. 
APGAR Score: The mean value of APGAR score at 5 
min in groups A and B was 8.84±0.80 and 9.12±0.66, 
respectively, showing no significant difference 
between them. The mean value of APGAR score at 5 
min in group A and group B were 9.68±0.47 and 
9.80±0.40, respectively, and showed no significant 
difference between the two groups (Table 5). 
Table 1: Patient demographics. 
 
Group A Group B P-value 
Mean(bpm) SD Mean(bpm) SD 
Baseline heart rate 90.6400 7.14656 92.3200 3.77183 0.304 
1 min post anesthesia 89.3600 7.82560 94.4000 5.14782 0.01* 
2 min post anesthesia 89.7600 7.55690 94.1600 5.79281 0.025 
3 min post anesthesia 90.4400 6.89251 91.3200 4.67012 0.61 
4 min post anesthesia 88.8000 7.25718 91.1600 3.84794 0.152 
5 min post anesthesia 88.2000 5.67891 90.3200 6.28967 0.217 
6 min post anesthesia 86.9600 7.12086 90.0800 4.60905 0.072 
7 min post anesthesia 88.1600 6.49153 90.4800 3.52515 0.125 
8 min post anesthesia 87.6400 6.74463 90.9600 5.67509 0.066 
9 min post anesthesia 87.4783 8.52733 91.4167 6.06427 0.077 
10 min post anesthesia 87.0588 8.19657 93.3158 5.91657 0.012* 
11 min post anesthesia 87.5000 5.68038 94.6364 2.41962 <0.001** 
12 min post anesthesia 93.0000 4.08248 94.0000 2.00000 0.4121 
13 min post-anesthesia 95.5000 3.53553 95.0000 - 0.8741 
The chi-square test, *significant; **highly significant; if the p value is >0.05, not significant. 
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Discussion 
Phenylephrine was used for all the patients, and no 
other drug was given intraoperatively before extraction 
of the baby. This makes the possibility of influences of 
other drugs on our study drug remote. All the patients 
had similar demographic parameters in our study 
group, which made their influence very unlikely.  
Following spinal anesthesia for Caesarean 
section, hypotension remains a major drawback, with 
an incidence of up to 85% reported in the literature. 
This is despite pregnant patients having 40-50% of 
more blood volume at term than nonpregnant patients. 
Pregnants at term are more prone to develop 
hypotension due to the occurrence of aortocaval 
compression by the fetal head and a higher level of 
sympathetic blockade owing to increased spread of 
local anesthetic in the cerebrospinal fluid (12). 
Hypotension, hazardous to the mother and more so, is 
better prevented than treated to the fetus. Blood 
pressure is usually maintained in the face of 
vasodilation, caused due to factors other than central 
neural blockade, by a reflexive increase in cardiac 
output. However, in the presence of spinal-induced 
venodilation, venous return is reduced to the extent that 
cardiac output cannot increase and is often reduced. 
The result is severe hypotension with reduced 
uteroplacental perfusion and APGAR score. 
The current study compares prophylactic 
infusion of Phenylephrine and a control group not 
receiving the infusion to prevent hypotension during 
spinal anesthesia for cesarean section. However, both 
the groups received a bolus dose of phenylephrine 
100µg intravenous to treat any episodes of 
hypotension. 
Table 2: Comparison of SBP (mm Hg) between two groups. 
 Group A Group B P 
value 
Mean SD Mean SD 
Baseline  123.3600 8.58235 124.2400 6.67882 0.688 
1 min post anesthesia 125.2000 8.18026 126.8400 9.89815 0.526 
2 min post anesthesia 123.8400 10.07340 116.8400 13.00538 0.039 
3 min post anesthesia 125.5200 7.78417 103.0800 12.87413 0.000* 
4 min post anesthesia 124.4000 7.92675 98.4400 10.63046 0.000* 
5 min post anesthesia 124.4000 9.90791 101.0000 10.88577 0.000* 
6 min post anesthesia 123.3200 10.72272 103.6800 8.81627 0.000* 
7 min post anesthesia 126.2800 9.87218 108.3200 8.77363 0.000* 
8 min post anesthesia 125.9200 6.74463 109.5200 8.79924 0.000* 
9 min post anesthesia 125.3182 11.38665 109.3333 7.08131 0.000* 
10 min post anesthesia 128.4706 4.73178 109.7895 9.36055 0.000* 
11 min post anesthesia 128.4000 6.80126 110.0000 8.63713 0.000* 
12 min post anesthesia 127.0000 8.98146 109.4000 7.79744 0.005* 
13 min post anesthesia 123.0000 4.24264 100.0000 8.2556 0.141 
The chi-square test, *significant; if the p-value is >0.05, not significant. 
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Effect on maternal hemodynamics: The study 
observed that during the initial part of the study at 1-2 
minutes and later part of the study from 10th to 11th 
minute, the heart rate was higher in the group B 
patients compared to that of group A. This is probably 
due to reflex bradycardia caused by the phenylephrine 
infusion in group A which lowered the heart rate. 
However, between the 3rd and 9th minute, the heart rate 
was comparable in both the groups. This was because 
of the phenylephrine boluses given to the patients in 
group B to treat the hypotension episodes, which 
caused reflex bradycardia. However, none of the 
Table 3: Comparison of DBP (mm Hg) between two groups. 
Study period Group A Group B P-value 
Mean SD Mean SD 
Baseline DBP 74.5200 4.69148 72.2800 4.37340 0.087 
1 min post anesthesia 75.4800 6.47508 74.2400 5.87566 0.4605 
2 min post anesthesia 74.2400 6.58458 71.7200 5.87026 0.1628 
3 min post anesthesia 74.6400 5.36097 67.4800 6.15169 <0.0001** 
4 min post anesthesia 73.8000 8.54888 65.4000 6.87386 0.0004* 
5 min post anesthesia 73.6400 7.89979 63.4800 14.19542 0.0031* 
6 min post anesthesia 72.7600 8.08435 67.0400 5.55638 0.0048* 
7 min post anesthesia 72.8800 6.99595 69.0000 6.95821 0.0537 
8 min post anesthesia 73.8800 6.95414 68.7600 4.71946 0.0039* 
9 min post anesthesia 73.6522 8.13303 68.6250 3.92110 0.0069* 
10 min post anesthesia 75.5882 4.95049 67.8947 7.40041 0.0001* 
11 min post anesthesia 76.1333 5.54033 70.9091 3.14498 0.0101* 
12 min post anesthesia 78.2857 6.34335 70.0000 1.58114 0.0177* 
13 min post-anesthesia 81.0000 2.82843 72.0000 - 0.1388 
The chi-square test, *significant; **highly significant; if the p value is >0.05, not significant. 
 
Table 5: Usage of Phenylephrine: Intravenous Fluids, Duration from Skin Incision to Delivery of Baby Umbilical 
Artery Blood pH. 
 Group A Group B P value 
Usage of Phenylephrine 496 ±280.59  216 ±94.33 0.0001* 
Intravenous Fluids(ml) 105.60 ± 14.74 104.00±12.24 0.678 
Duration from Skin Incision to delivery of 
baby(Sec) 
532.8±60.17  530.4±59.19  0.89 
Umbilical artery blood pH 7.1736±0.03121  7.1756±.02740  0.811 
APGAR score @1 minute 8.84±0.80 9.12±0.66 0.185 
APGAR score @5 minute 9.68±0.47 9.80±0.40 0.344 
The chi-square test, *significant; if the p-value is >0.05, not significant. 
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patients require treatment with atropine in both groups. 
These findings suggest infusion keeps the heart rate 
uniformly but on a lower side than the boluses where a 
fluctuation in the heart rate was observed. 
The current study results correlate with the 
recent study by Joo Yeon Jeon et al. and Patel et al. (13, 
14). 
Sharma et al. found that the mean heart rate 
decreased significantly after administration of 
phenylephrine boluses whereas it remained high in the 
patients receiving mephentermine (15). Also, Thomas 
et al. found that more than 50% of women given 
Phenylephrine developed significant bradycardia 
compared to the ephedrine group (5). As the cardiac 
output is the heart rate and stroke volume product, this 
suggests that Phenylephrine restored a greater stroke 
volume than Ephedrine. Because Phenylephrine is 
virtually devoid of β-inotropic effect, the better stroke 
volume produced by Phenylephrine probably reflects 
better preload than Ephedrine (14). Nevertheless, in the 
ephedrine group, cardiac sympathetic denervation was 
masked by the chronotropic effect of this β adrenergic 
agonist. Hall et al. also recorded 2 cases of bradycardia 
in the phenylephrine group, which was less than 
40beats/min, corrected with a bolus dose of atropine 
(16). All these episodes occurred after multiple doses 
of Phenylephrine, and no patients developed 
bradycardia. The findings of Patel et al. were consistent 
with our study and suggest that Phenylephrine causes 
reflex bradycardia (14). 
 
Blood pressure: In our study, we also observed that 
hypotension incidence is 3.57% (n=1/25) in group A 
and 100% in group B. It was observed that the 
incidence of hypotension was higher in group B. This 
reflects that more stable management of blood pressure 
can be achieved by phenylephrine infusion as it 
uniformly maintains the plasma level of this 
vasopressor. 
Our study observed that the difference in 
systolic blood pressure, diastolic blood pressure, and 
mean blood pressure was highly significant between 
the two groups. 
The SBP, DBP, and mean blood pressure was 
consistently higher in Group A when compared to 
Group B. This probably was due to post-synaptic α 
receptors' stimulation by Phenylephrine, resulting in 
intense arterial and peripheral venoconstriction 
causing a rise in blood pressure. 
However, we found that the required dose of 
Phenylephrine was much higher in the infusion group 
than in the control group. At term, the uterine vascular 
bed is maximally vasodilated and unable to 
autoregulate when perfusion pressure is reduced. 
Consequently, a higher adrenoceptor density renders 
uteroplacental blood flow potentially vulnerable to 
vasoconstriction induced by α adrenergic agonists. 
Indeed, infusion of Phenylephrine at 8µg/kg/min has 
been reported to decrease uteroplacental blood flow by 
50% however, the relationship between phenylephrine 
dose and uterine vascular resistance is not linear and 
dramatic increases in Uterine vascular resistance seen 
only to appear with doses greater than 100µg/min thus, 
the satisfactory fetal outcome in human studies may 
reflect the lower doses used. This is consistent with our 
study, where the infusion rate was 100µg/min.  
 
Non-hemodynamic side effects: In our study, no 
patient developed nausea or vomiting (who received 
Phenylephrine). Cooper et al. suggest that the possible 
explanation for nausea and vomiting is increased vagal 
tone following preload reduction (7). Cardiac preload 
decreased in spinal anesthesia, but phenylephrine, a 
pure α- agonist, provides better venoconstriction, 
reducing the cardiac preload and diminishing the vagal 
reflex (17). Sarvanan et al. found that Phenylephrine 
was significantly better among the patients with 
ineffective blood pressure control than Ephedrine in 
the prevention of vomiting (17). 
According to our research, all the studies 
demonstrated a lower incidence of nausea and 
vomiting in patients receiving Phenylephrine (18, 19). 
 
Neonatal outcome: The APGAR scores and measured 
umbilical artery blood pH were used to indicate the 
adequacy of placental perfusion. Despite periods of 
maternal hypotension in group B and decreased heart 
rate in group A, we found no significant difference in 
either APGAR score or umbilical artery blood pH 
between the two groups. This could be due to 
immediate correction of hypotension episodes and 
maintenance of uteroplacental perfusion in both 
groups.  
The APGAR score was similar in the groups and 
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never less than 8, although the incidence of arterial pH 
< 7.18 was greater than desired. Several studies 
reported a surprisingly high incidence of acidosis (not 
accompanied by neonatal depression) after spinal 
anesthesia for cesarean deliveries (19, 20). Another 
mechanism for decreased uterine artery blood pH is by 
a prolonged period of decreased maternal cardiac 
output occurring before delivery. The results of our 
study demonstrate that the higher umbilical artery pH 
and the incidence of nausea and vomiting were null 
when Phenylephrine is titrated with aim of maintaining 
the maternal BP at 100% of a baseline compared with 
<90% or <80% baseline. Robson et al. found that 
umbilical artery blood pH correlated well with 
maternal cardiac output (but not with BP itself) (21). 
Also, Hall and coworkers found that despite 
periods of maternal hypotension, which occurred 
longer than 2 min, and periods of maternal bradycardia, 
there was no significant difference in either APGAR 
scores or blood-gas data between the three groups (16). 
Joupilla et al. also showed that intravenous preload 
maintains placental blood flow despite moderate 
maternal pressure reduction, thus minimizing fetal 
acidosis. Our study is taken precautions by preloading 
the patientswith10ml/kg of Ringer lactate solution, 
which probably would have maintained placental 
blood flow during hypotensive episodes lasting longer 
than 2minutes (22). Recent studies have also shown 
that Phenylephrine in bolus or infusion has no adverse 
neonatal effects (16, 17, 23). 
 
Conclusion 
Prophylactic phenylephrine infusion is superior for the 
control of hemodynamics. When given as a 
prophylactic infusion, the results suggest that 
Phenylephrine leads to significantly the best control of 
post-spinal hypotension during c-section with no 
maternal side effects. The APGAR scores and fetal 
acid-base status did not show any evidence of acidosis, 
which was similar. The prophylactic phenylephrine 
infusion is the simple method for managing better fetal 
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